Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 4/20 | 0.54 |
| ▸ | TOP1 | P11387 | 4/20 | 0.54 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.53 |
| ▸ | CYCS | P99999 | 3/20 | 0.51 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.43 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.43 |
| ▸ | AURKA | O14965 | 1/20 | 0.42 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.42 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL21111503 | 0.97 | TERT (0.54) | TERTTOP1ABCG2CYCSENPP2 | |
| Hydrochloric Acid SCHEMBL31122235 | 0.97 | TERT (0.54) | TERTTOP1ABCG2CYCSENPP2 | |
| SCHEMBL949511 | 0.97 | TERT (0.57) | TERTTOP1ABCG2CYCSENPP2 | |
| SCHEMBL29414382 | 0.97 | TERT (0.57) | TERTTOP1ABCG2CYCSENPP2 | |
| SCHEMBL2338257 | 0.95 | TERT (0.55) | TERTTOP1ABCG2CYCSENPP2 | |
| SCHEMBL20856304 | 0.95 | TERT (0.59) | TERTTOP1ABCG2CYCSENPP2 | |
| SCHEMBL22265228 | 0.95 | TERT (0.55) | TERTTOP1ABCG2CYCSENPP2 | |
| Hydrochloric Acid SCHEMBL15768782 | 0.95 | TERT (0.55) | TERTTOP1ABCG2CYCSENPP2 | |
| SCHEMBL8430292 | 0.95 | TERT (0.55) | TERTTOP1ABCG2CYCSENPP2 | |
| SCHEMBL29515314 | 0.95 | TERT (0.55) | TERTTOP1ABCG2CYCSENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11078302-B2 | Polymerization methods | NORTH CAROLINA STATE UNIVERSITY (US) | 2021-08-03 | — | — | US | claimed |
| US-20190345269-A1 | POLYMERIZATION METHODS | NORTH CAROLINA STATE UNIVERSITY | 2019-11-14 | — | — | US | claimed |
| CN-106290631-B | A kind of method of pigment array sensing technology Fast Evaluation magma Quality of Liquors | 江苏今世缘酒业股份有限公司 | 2018-11-27 | — | — | CN | claimed |
| CN-106290631-A | A kind of method of pigment array sensing technology Fast Evaluation original plasm wine quality | 江苏今世缘酒业股份有限公司 | 2017-01-04 | — | — | CN | claimed |
| US-20250270352-A1 | METHODS OF REVERSIBLE-ADDITION FRAGMENTATION CHAIN TRANSFER STEP-GROWTH POLYMERIZATION AND POLYMERS THEREFROM | NATIONAL SCIENCE FOUNDATION | 2025-08-28 | — | — | US | disclosed |
| EP-2602655-B1 | Ophthalmic filter | ESSILOR INT (FR) | 2024-04-03 | — | — | EP | disclosed |
| CN-117783019-A | On-site detection method of CTC black tea production place based on solution phase color sensing array | 安徽农业大学 | 2024-03-29 | — | — | CN | disclosed |
| US-11865521-B2 | Bifunctional catalyst for hydrogenation of carbon dioxide, and method for preparing hydrocarbon by using same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2024-01-09 | — | — | US | disclosed |
| US-11635547-B2 | Composition for the manufacture of an ophthalmic lens comprising an encapsulated light-absorbing additive | ESSILOR INTERNATIONAL (FR) | 2023-04-25 | — | — | US | disclosed |
| EP-2602654-B1 | Ophthalmic filter | ESSILOR INT (FR) | 2023-04-19 | — | — | EP | disclosed |
| EP-3497488-B2 | OPHTALMIC LENS COMPRISING AN ENCAPSULATED LIGHT-ABSORBING ADDITIVE | ESSILOR INT (FR) | 2023-03-22 | — | — | EP | disclosed |
| WO-2023034335-A1 | METHODS OF REVERSIBLE-ADDITION FRAGMENTATION CHAIN TRANSFER STEP-GROWTH POLYMERIZATION AND POLYMERS THEREFROM | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-03-09 | — | — | WO | disclosed |
| WO-2013084177-A1 | OPHTHALMIC FILTER | Essilor International (Compagnie Générale d'Optique) (FR) | 2013-06-13 | — | — | WO | disclosed |
| WO-2013084178-A1 | OPHTHALMIC FILTER | Essilor International (Compagnie Générale d'Optique) (FR) | 2013-06-13 | — | — | WO | disclosed |
| WO-2013084176-A1 | METHOD OF DETERMINING THE CONFIGURATION OF AN OPHTHALMIC FILTER | Essilor International (Compagnie Générale d'Optique) (FR) | 2013-06-13 | — | — | WO | disclosed |
| EP-2602655-A1 | Ophthalmic filter | Essilor International (Compagnie Générale D'Optique) (FR) | 2013-06-12 | — | — | EP | disclosed |
| EP-2602653-A1 | Method of determining the configuration of an ophthalmic filter | Essilor International (Compagnie Générale D'Optique) (FR) | 2013-06-12 | — | — | EP | disclosed |
| EP-2602654-A1 | Ophthalmic filter | Essilor International (Compagnie Générale D'Optique) (FR) | 2013-06-12 | — | — | EP | disclosed |
| EP-1704057-A1 | LASER IMAGING | Sherwood Technology LTD. (GB) | 2006-09-27 | — | — | EP | disclosed |
| WO-2005068207-A1 | LASER IMAGING | DATALASE LTD. (GB) | 2005-07-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11865521-B2 | Bifunctional catalyst for hydrogenation of carbon dioxide, and method for preparing hydrocarbon by using same | TDO2, SCO2, HAO2 | TERT 58/4885TOP1 352/4885ABCG2 4720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.